The pharmaceutical business is a dynamic part of the larger healthcare ecosystem. The pharmaceutical industry mainly deals with the development of medications and scientific research activities that avert or treat ailments and disorders. Pharmaceutical manufacturing is the process of commercial-scale creation of medicines by pharmaceutical establishments. The rising demand for modernization of pharmaceutical manufacturing procedure has prompted leading companies to employ new technologies such as continuous pharmaceutical manufacturing. This technology offers superiority, probable flexibility, and economic rewards over batch processing, together in process manufacturing and development for the pharmaceutical sector. Features such as rising geriatric population, growing prevalence of chronic ailments, high investment in research and development, increasing focus on outsourcing manufacturing activities, increasing per capita healthcare expenditure, rising incidence of novel viral diseases, technological advancements in manufacturing processes, and improving reimbursement scenario in developing regions are driving the development of pharmaceutical manufacturing market. Improved focus on elderly and pediatric patients, growing demand for home-based healthcare, high incidence of cardiovascular disorders, and increased cancer and diabetes cases are further propelling the pharmaceutical manufacturing market expansion across the globe.
Pharmaceutical Manufacturing Market is projected to grow up to US$ 950 billion by 2028 growing at a CAGR of 13.74%during the forecasting period 2023-2028.
Report Scope
The global market report scope consists of a comprehensive study covering primary factors impacting the industry trends. The study includes analysis of regional and country-level market dynamics. The scope also consists of competitive overview offering company market shares coupled with company profiles for key revenue contributing companies. The report scope covers a detailed competitive outlook covering market shares and profiles of key participants in the market share.
Major Market Players
The key players of the market are F. Hoffmann-La Roche Ltd., Novartis AG, GlaxoSmithKline plc, Pfizer, Inc., AstraZeneca, Merck & Co., Inc., Johnson & Johnson, Sanofi SA, Eli Lilly and Company and Lonza.
The Pharmaceutical ManufacturingMarket report has been categorized as below
By Drug Development Type
By Formulation Outlook
By Route of Administration Outlook
By Therapy Area Outlook
By Prescription Outlook
By Age Group Outlook
By Distribution Channels Outlook
By Region
The years considered for the study are as follows:
Key Questions Addressed by the Report
Why Buy this Report:
Size, Share, Analysis Report
Below are our New Reports :-
1. Pharmaceutical ManufacturingMarket Introduction
1.1. Key Insights
1.2. Report Overview
1.3. Markets Covered
1.4. Stakeholders
2. Research Methodology
2.1. Research Scope
2.2. Market Research Process
2.3. Research Data Analysis
2.4. Market Size Estimation
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Drivers and Restraints
5. By Drug Development Type
5.1. Key Points
5.2. Outsource
5.3. In-house
6. By Formulation Outlook
6.1. Key Points
6.2. Tablets
6.3. Capsules
6.4. Injectable
6.5. Sprays
6.6. Suspensions
6.7. Powders
6.8. Other Formulations
7. By Route of Administration Outlook
7.1. Key Points
7.2. Oral
7.3. Topical
7.4. Parenteral
7.5. Inhalations
7.6. Other Routes of Administration
8. By Therapy Area Outlook
8.1. Key Points
8.2. Cardiovascular Diseases
8.3. Pain
8.4. Diabetes
8.5. Cancer
8.6. Respiratory Diseases
8.7. Other Diseases
9. By Prescription Outlook
9.1. Key Points
9.2. Prescription Medicines
9.3. Over-the-counter (OTC) Medicines
10. By Age Group Outlook
10.1. Key Points
10.2. Children & Adolescents
10.3. Adults
10.4. Geriatric
11. By Distribution Channels Outlook
11.1. Key Points
11.2. Retail
11.3. Non-retail
12. By Region
12.1. Key Points
12.2. North America
12.3. Europe
12.4. Asia Pacific
12.5. Rest of the World
13. Company Profile
(Profile contain company overview, products/services, financials & recent developments)
13.1. F. Hoffmann-La Roche Ltd.
13.2. Novartis AG
13.3. GlaxoSmithKline plc
13.4. Pfizer, Inc.
13.5. AstraZeneca
13.6. Merck & Co., Inc.
13.7. Johnson & Johnson
13.8. Sanofi SA
13.9. Eli Lilly and Company
13.10. Lonza
The Pharmaceutical ManufacturingMarket report has been categorized as below
By Drug Development Type
By Formulation Outlook
By Route of Administration Outlook
By Therapy Area Outlook
By Prescription Outlook
By Age Group Outlook
By Distribution Channels Outlook
By Region
SUBSCRIBE TO OUR NEWSLETTERS
